Patient Guide: A Study to Evaluate the Efficacy and Safety of Concomitant Use of Eplontersen and ALXN2220 Compared With Eplontersen and Placebo for Adults Participants With ATTR-CM.

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 78 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT07608354
Status: UPCOMING
Condition: Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Phase: PHASE2

Find a Study Location Near You

This study is available at 78 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • La Jolla, California
  • • San Francisco, California
  • • Stanford, California
  • • And 75 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Evaluate the Efficacy and Safety of Concomitant Use of Eplontersen and ALXN2220 Compared With Eplontersen and Placebo for Adults Participants With ATTR-CM. - Join Clinical Trial NCTNCT07608354

How to Join This Clinical Trial - NCTNCT07608354

Learn how to participate in this PHASE2 trial studying an investigational therapy for Transthyretin Amyloid Cardiomyopathy (ATTR-CM). Current status: UPCOMING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Transthyretin Amyloid Cardiomyopathy (ATTR-CM). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
UPCOMING
Study Identifier
NCTNCT07608354 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 78 locations. Find a study site near you:

Clinical Research Site

La Jolla, California 92037 - United States

Status: Contact for availability

Clinical Research Site

San Francisco, California 94115 - United States

Status: Contact for availability

Clinical Research Site

Stanford, California 94305 - United States

Status: Contact for availability

Clinical Research Site

Aurora, Colorado 80045 - United States

Status: Contact for availability

Clinical Research Site

Washington D.C., District of Columbia 20010 - United States

Status: Contact for availability

Clinical Research Site

Jacksonville, Florida 32224 - United States

Status: Contact for availability

Clinical Research Site

Miami, Florida 33176 - United States

Status: Contact for availability

Clinical Research Site

Weston, Florida 33331 - United States

Status: Contact for availability

Clinical Research Site

Chicago, Illinois 60637 - United States

Status: Contact for availability

Clinical Research Site

Boston, Massachusetts 02115 - United States

Status: Contact for availability

And 68 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Transthyretin Amyloid Cardiomyopathy (ATTR-CM):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation